Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

Student Researchers and COI Disclosures

Student researchers who are listed on human subjects research protocols are required to have an Outside Interest Disclosure form on file with the Office of Research Administration (ORA). To help establish that the design, conduct, and reporting of research will be free from bias resulting from Investigator financial conflict of interests, disclosures are required not only for faculty and staff, but also student researchers.

For more information on the CWRU Outside Interest Disclosure process, see: https://research.case.edu/Compliance/COI.cfm.

 
New Facilities and Administrative (F&A) Rate for Use in Proposals

Negotiations with the Department of Health and Human Services (DHHS) regarding the University’s F&A rates have concluded. DHHS has approved a (3) three year F&A rate of 58.5% for CWRU, which is a 1.5 percentage point change from our previous rate of 57%. This rate will be effective through June 2016.

The new F&A rate should be used when preparing proposal budgets for awards with an anticipated start date of July 1, 2013 or after.

Read the full notice of this change at: https://ora.ra.cwru.edu/research/docs/2012.10.08_Facilities_and_Administrative_rate.pdf.

 
Skin Diseases Research Center (SDRC)

The Skin Diseases Research Center is funded by a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. The goal of the Center is to foster translational and basic research in cutaneous biology and skin diseases. The SDRC sponsors innovative research through its Pilot and Feasibility (P&F) Program and plans to support three new P&F projects for funding for one year with an annual budget of $25,000 (direct costs). Projects are supported with the understanding that the PI will subsequently apply for NIH or equivalent funding using preliminary data acquired during the P&F project period.

Application Deadline: Feb. 27, 2015

For more information visit the CTSC pilot programs webpage.

 
NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC)

The NIH Center for Accelerated Innovation at Cleveland Clinic (NCAI-CC) Announces the Request for Applications (RFA) for the third funding cycle.

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, pulmonary, blood or sleep-related disorders. NCAI-CC is seeking projects such as therapeutics (e.g. drugs, biologics), preventatives, diagnostics, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health. The NCAI-CC will provide funding and project assistance to advance the development of high priority early-stage technologies within the mission areas of the NHLBI (cardiovascular, lung, blood and sleep disorders). Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

Eligibility: Investigators from the Cleveland Clinic, Case Western Reserve University, The Ohio State University,Cincinnati Children’s Hospital, and University of Cincinnati

Letter of Intent Deadline: February 10, 2015

For more information visit the NCAI-CC website.

 
NEW Limited Submission: American Diabetes Association Pathway to Stop Diabetes

Key Deadlines: March 2, 2015, 5:00pm (CWRU Internal Submission Deadline), July 1, 2015, 8:00pm EST.

To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association has launched a bold initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, treatment and cures.

Pathway will support creative scientists early in their diabetes research careers, or investigators who are established in other disciplines but would like to expand their focus to diabetes research. Through awards of $1.625 million over the course of up to seven years, the program will provide researchers the freedom, autonomy, time and focus needed to explore new ideas.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.